U.S. FDA advisers back Moderna COVID-19 vaccine for small children
© Reuters. FILE PHOTO: Moderna’s logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic
(Reuters) – U.S. Food and Drug Administration advisers on Wednesday recommended the authorization of Moderna (NASDAQ:MRNA) Inc’s COVID-19 vaccine for children aged 6 months through 5 years, an important step toward immunizing millions children who have been ineligible for the shots during the pandemic.
The same panel of outside experts is expected to vote within an hour on whether or not to recommend the Pfizer-BioNTech vaccine for children aged 6 months through 4 years old.
More Stories
Oil inches higher as Middle East tensions heat up
© Reuters. Army soldier miniatures and stock graph are seen in this illustration taken October 9, 2023. REUTERS/Dado Ruvic/Illustration/File Photo...
Asian stocks rise before US CPI; Japan’s Nikkei extends rally
. JP225 +1.88% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully to: + Add another position...
SEC approves spot Bitcoin ETFs
. SEC approves spot bitcoin ETFs BTC/USD +1.76% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully...
Google lays off hundreds in Assistant, hardware, engineering teams
© Reuters. The Google logo is seen on the Google house at CES 2024, an annual consumer electronics trade show,...
US SEC approves bitcoin ETFs in watershed for crypto market
© Reuters. FILE PHOTO: FILE PHOTO: U.S. Securities and Exchange Commission logo and representations of cryptocurrency are seen in this...
Amazon has not offered remedies to EU concerns over iRobot deal
© Reuters. FILE PHOTO: The logo of Amazon is seen at the company's logistics centre in Boves, France, October 6,...